FORTERRE GAEL (Chief Commercial Officer) received a stock award from VOLITIONRX LTD
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/26/2024ACC: 0001477932-24-000417
Officer· Chief Commercial Officer
Since Feb 2021
+25.93K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
25.93K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.93K
Price / share
—
Trade value
—
% of position
25.4%
—
102.25K→128.18K
Total
Net shares
+25.93K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | A · Award | +25.93K | — | — | 25.4% | 102.25K | 128.18K |
| Total | +25.93K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned32.50K
Common Stock
IndirectShares owned5K
Total
37.50K indirect37.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 32.50K | Indirect |
| Common Stock | 5K | Indirect |
| Total | 37.50K | 37.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported